Dow Up 1.11% Nasdaq Up 1.84%

Zogenix, Inc. (ZGNX)

-NasdaqGM
1.31 Down 0.07(5.07%) 1:35PM EDT - Nasdaq Real Time Price
Prev Close:1.38
Open:1.40
Bid:1.31 x 5900
Ask:1.32 x 8500
1y Target Est:3.10
Beta:1.27
Next Earnings Date:N/A
Day's Range:1.31 - 1.40
52wk Range:1.07 - 5.19
Volume:480,076
Avg Vol (3m):1,768,790
Market Cap:184.77M
P/E (ttm):N/A
EPS (ttm):-0.18
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZGNXDown 5.07%184.77M
AZNUp 1.35%86.98B
GSKUp 0.21%104.97B
PFEUp 1.63%179.99B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.74
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.68
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:1.2
PEG Ratio (5 yr expected):-0.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company’s commercial product includes Zohydro, a single-entity extended-release hydrocodone for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback